Qvt Financial LP Roivant Sciences Ltd. Transaction History
Qvt Financial LP
- $951 Million
- Q1 2025
A detailed history of Qvt Financial LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Qvt Financial LP holds 65,793,779 shares of ROIV stock, worth $708 Million. This represents 69.8% of its overall portfolio holdings.
Number of Shares
65,793,779
Previous 65,793,779
-0.0%
Holding current value
$708 Million
Previous $778 Million
14.71%
% of portfolio
69.8%
Previous 76.3%
Shares
5 transactions
Others Institutions Holding ROIV
# of Institutions
331Shares Held
496MCall Options Held
3.67MPut Options Held
754K-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$666 Million5.69% of portfolio
-
Viking Global Investors LP46MShares$495 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.8MShares$439 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$387 Million0.03% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$381 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.58B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...